Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies

A Corrigendum to this article was published on 01 March 2006

Abstract

Genome-wide association is a promising approach to identify common genetic variants that predispose to human disease1,2,3,4. Because of the high cost of genotyping hundreds of thousands of markers on thousands of subjects, genome-wide association studies often follow a staged design in which a proportion (πsamples) of the available samples are genotyped on a large number of markers in stage 1, and a proportion (πsamples) of these markers are later followed up by genotyping them on the remaining samples in stage 2. The standard strategy for analyzing such two-stage data is to view stage 2 as a replication study and focus on findings that reach statistical significance when stage 2 data are considered alone2. We demonstrate that the alternative strategy of jointly analyzing the data from both stages almost always results in increased power to detect genetic association, despite the need to use more stringent significance levels, even when effect sizes differ between the two stages. We recommend joint analysis for all two-stage genome-wide association studies, especially when a relatively large proportion of the samples are genotyped in stage 1 (πsamples ≥ 0.30), and a relatively large proportion of markers are selected for follow-up in stage 2 (πmarkers ≥ 0.01).

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Power of a two-stage design for joint and replication-based analysis with 1,000 cases and 1,000 controls genotyped on 300,000 independent markers with αgenome = 0.05.
Figure 2: Power of a two-stage design for joint and replication-based analysis with 1,000 cases and 1,000 controls genotyped on 300,000 independent markers with αgenome = 0.05, using a GRR of 1.40 and prevalence of 0.10.
Figure 3: Power of a two-stage design for joint and replication-based analysis with 1,000 cases and 1,000 controls genotyped on 300,000 independent markers with αgenome = 0.05, using a GRR of 1.40 and prevalence of 0.10.
Figure 4: Power of a two-stage design for joint and replication-based analyses in the presence of between-stage heterogeneity with 1,000 cases and 1,000 controls genotyped on 300,000 independent markers with αgenome = 0.05.

Similar content being viewed by others

References

  1. Risch, N. & Merikangas, K. The future of genetic studies of complex human diseases. Science 273, 1516–1517 (1996).

    Article  CAS  Google Scholar 

  2. Hirschhorn, J.N. & Daly, M.J. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6, 95–108 (2005).

    Article  CAS  Google Scholar 

  3. Kruglyak, L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat. Genet. 22, 139–144 (1999).

    Article  CAS  Google Scholar 

  4. Cardon, L.R. & Bell, J.I. Association study designs for complex diseases. Nat. Rev. Genet. 2, 91–99 (2001).

    Article  CAS  Google Scholar 

  5. Klein, R.J. et al. Complement factor H polymorphism in age-related macular degeneration. Science 308, 385–389 (2005).

    Article  CAS  Google Scholar 

  6. Sachidanandam, R. et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928–933 (2001).

    Article  CAS  Google Scholar 

  7. The International HapMap Consortium. The International HapMap Project. Nature 426, 789–796 (2003).

  8. Hinds, D.A. et al. Whole-genome patterns of common DNA variation in three human populations. Science 307, 1072–1079 (2005).

    Article  CAS  Google Scholar 

  9. Johnson, G.C.L. et al. Haplotype tagging for the identification of common disease genes. Nat. Genet. 29, 233–237 (2001).

    Article  CAS  Google Scholar 

  10. Ke, X. & Cardon, L.R. Efficient selective screening of haplotype tag SNPs. Bioinformatics 19, 287–288 (2003).

    Article  CAS  Google Scholar 

  11. Stram, D.O. et al. Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the multiethnic cohort study. Hum. Hered. 55, 27–36 (2003).

    Article  Google Scholar 

  12. Satagopan, J.M., Venkatraman, E.S. & Begg, C.B. Two-stage designs for gene-disease association studies with sample size constraints. Biometrics 60, 589–597 (2004).

    Article  Google Scholar 

  13. Satagopan, J.M., Verbel, D.A., Venkatraman, E.S., Offit, K.E. & Begg, C.B. Two-stage designs for gene-disease association studies. Biometrics 58, 163–170 (2002).

    Article  Google Scholar 

  14. Thomas, D., Xie, R.R. & Gebregziabher, M. Two-stage sampling designs for gene association studies. Genet. Epidemiol. 27, 401–414 (2004).

    Article  Google Scholar 

  15. Devlin, B., Roeder, K. & Wasserman, L. Genomic control, a new approach to genetic-based association studies. Theor. Popul. Biol. 60, 155–166 (2001).

    Article  CAS  Google Scholar 

  16. Hinds, D.A. et al. Matching strategies for genetic association studies in structured populations. Am. J. Hum. Genet. 74, 317–325 (2004).

    Article  CAS  Google Scholar 

  17. Pritchard, J.K. & Donnelly, P. Case-control studies of association in structured or admixed populations. Theor. Popul. Biol. 60, 227–237 (2001).

    Article  CAS  Google Scholar 

  18. Ripatti, S., Pitkaniemi, J. & Sillanpaa, M.J. Joint modeling of genetic association and population stratification using latent class models. Genet. Epidemiol. 21, S409–S414 (2001).

    Article  Google Scholar 

  19. Satten, G.A., Flanders, W.D. & Yang, Q.H. Accounting for unmeasured population substructure in case-control studies of genetic association using a novel latent-class model. Am. J. Hum. Genet. 68, 466–477 (2001).

    Article  CAS  Google Scholar 

  20. Shmulewitz, D., Zhang, J.Y. & Greenberg, D.A. Case-control association studies in mixed populations: Correcting using genomic control. Hum. Hered. 58, 145–153 (2004).

    Article  CAS  Google Scholar 

  21. Yang, B.Z., Zhao, H.Y., Kranzler, H.R. & Gelernter, J. Practical population group assignment with selected informative markers: characteristics and properties of Bayesian clustering via STRUCTURE. Genet. Epidemiol. 28, 302–312 (2005).

    Article  Google Scholar 

Download references

Acknowledgements

This research was supported by the US National Institutes of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Boehnke.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Table 1

Significance thresholds and power of joint and replication-based analysis for a number of two-stage genome-wide association designs. (PDF 219 kb)

Supplementary Table 2

Power of joint and replication-based analysis for a number of two-stage genome-wide association designs. (PDF 190 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Skol, A., Scott, L., Abecasis, G. et al. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38, 209–213 (2006). https://doi.org/10.1038/ng1706

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng1706

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing